These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15115902)

  • 1. Lack of anti-ischemic efficacy of the potassium channel opener bimakalim in patients with stable angina pectoris.
    Burian M; Piske M; Petkovic D; Mitrovic V
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):37-46. PubMed ID: 15115902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists.
    Mitrovic V; Oehm E; Thormann J; Pitschner H; Hamm C
    Herz; 2000 Mar; 25(2):130-42. PubMed ID: 10829253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
    Yao Z; Gross GJ
    Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of the calcium channel blocker pranidipine on exercise-induced angina.
    Nishinaka Y; Yokota M; Watanabe M; Sobue T; Iwase M; Ukai M; Ando A; Nagata K; Saito H
    Int J Clin Pharmacol Ther; 1994 Oct; 32(10):542-9. PubMed ID: 7834162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lack of bronchodilator effect and the short-term safety of cumulative single doses of an inhaled potassium channel opener (bimakalim) in adult patients with mild to moderate bronchial asthma.
    Faurschou P; Mikkelsen KL; Steffensen I; Franke B
    Pulm Pharmacol; 1994 Oct; 7(5):293-7. PubMed ID: 7626915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bimakalim (EMD 52692), an opener of ATP sensitive potassium channels, on infarct size, coronary blood flow, regional wall function, and oxygen consumption in swine.
    Rohmann S; Weygandt H; Schelling P; Soei LK; Becker KH; Verdouw PD; Lues I; Häusler G
    Cardiovasc Res; 1994 Jun; 28(6):858-63. PubMed ID: 7923292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pharmacological modulation of the ATP-sensitive potassium channels on the development of warm-up angina pectoris.
    Lindhardt TB; Abedini S; Olesen RM; Haunsø S; Gadsbøll N
    Cardiology; 2006; 105(1):17-21. PubMed ID: 16166774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of the K(+) channel blocker tedisamil on hemodynamics, myocardial ischemia and neurohumoral systems in patients with stable angina pectoris. A comparison with the beta blocker atenolol].
    Mitrovic V; Miskovic A; Straub M; Beckmann K; Thormann J; Pitschner H
    Z Kardiol; 1999 Oct; 88(10):838-49. PubMed ID: 10552188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent hemodynamic effects of bimakalim, a new potassium channel opener, in humans.
    Senior R; Buchner-Moell D; Raftery E; Lahiri A
    J Cardiovasc Pharmacol; 1993 Nov; 22(5):717-21. PubMed ID: 7506324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of the novel potassium channel opener bimakalim in conscious pigs after myocardial infarction: a comparative study with nicorandil.
    van Woerkens LJ; Baas NR; van der Giessen WJ; Verdouw PD
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):409-17. PubMed ID: 1387797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of administration of nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits.
    Das B; Sarkar C; Karanth KS
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):383-96. PubMed ID: 11692221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of human myocardium in vitro by K(ATP) activation with low concentrations of bimakalim.
    Picard S; Criniti A; Iwashiro K; Rouet R; Monti F; Tonelli E; Ruvolo G; Ducouret P; del Monte F; Papalia U; Puddu PE
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):162-72. PubMed ID: 10413083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic and hemodynamic effects of nicardipine during pacing-induced angina pectoris.
    Thomassen A; Bagger JP; Nielsen TT; Henningsen P
    Am J Cardiol; 1987 Feb; 59(4):219-24. PubMed ID: 3812268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and antiischemic effects of intravenous elgodipine, a new dihydropyridine calcium channel blocker, in patients with chronic stable angina.
    Kuhn A; Carlsson J; Miketic S; Tebbe U
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):595-600. PubMed ID: 8547210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine.
    Fujisawa M; Yorikane R; Matsuoka Y; Koike H; Ueno K
    J Cardiovasc Pharmacol; 2013 Jan; 61(1):63-9. PubMed ID: 23288106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The new potassium channel blocker tedisamil and its hemodynamic, anti-ischemic and neurohumoral effect in patients with coronary heart disease].
    Mitrovic V; Oehm E; Strasser R; Schlepper M; Pitschner HF
    Z Kardiol; 1996 Dec; 85(12):961-72. PubMed ID: 9082675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind comparison of 10 and 20 mg lercanidipine in patients with stable effort angina: effects on myocardial ischemia and heart rate variability.
    Acanfora D; Trojano L; Gheorghiade M; Picone C; Papa A; Furgi G; Giuliano F; Maestri R; Rengo F
    Am J Ther; 2002; 9(5):444-53. PubMed ID: 12237738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallopamil in chronic stable angina: antianginal effect and mechanism of action. A randomized, placebo-controlled, double-blind, cross-over trial.
    Zanolla L; Carbonieri E; Rossi L; Marino P; Zardini P
    Cardiology; 1992; 80(5-6):324-31. PubMed ID: 1451119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.